When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The FDA didn't bring peptides back. It opened a formal docket. And that distinction matters. This is not a blanket approval. Not a wellness free for all. Not one announcement that changes everything overnight. BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026)